Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978608810> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W1978608810 endingPage "297" @default.
- W1978608810 startingPage "290" @default.
- W1978608810 abstract "This study compared the intraocular pressure (IOP)-lowering efficacy of fixed-combination brinzolamide 1%/brimonidine 0.2% (BBFC) with that of its component medications, brinzolamide and brimonidine, in patients with open-angle glaucoma or ocular hypertension.In this phase 3, multicenter, double-masked, parallel-group, 3-month study with a 3-month safety extension, eligible patients were randomized 1:1:1 to treatment with BBFC, brinzolamide, or brimonidine thrice daily after a washout period, during which any IOP-lowering medications were discontinued. The primary objectives of this study were to determine whether the IOP-lowering efficacy of BBFC was superior to that of brinzolamide alone and, separately, of brimonidine alone. IOP was assessed at 8:00 AM, 10:00 AM, 3:00 PM, and 5:00 PM at 2 weeks, 6 weeks, and 3 months after study drug initiation.A total of 690 patients were enrolled in the study, and 615 completed the 3-month visit. Baseline mean IOP levels were similar among the 3 treatment groups at each of the 4 time points assessed. At the 3-month primary endpoint, mean IOP of the BBFC group was significantly lower than that of either the brinzolamide group or the brimonidine group (P≤0.005) across all time points. At the 2- and 6-week supportive endpoints, mean IOP of the BBFC group was significantly lower at all time points than the mean IOP of either the brinzolamide group (P≤0.01) or the brimonidine group (P<0.0001). A total of 143 patients experienced at least 1 treatment-related adverse event (AE; BBFC group, n=58, 26.2%; brinzolamide group, n=44, 18.8%; brimonidine group, n=41, 17.4%), the majority of which were ocular AEs.This study demonstrated that BBFC has significantly superior IOP-lowering activity compared with either brinzolamide 1% or brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension while providing a safety profile which is consistent with that of the individual components." @default.
- W1978608810 created "2016-06-24" @default.
- W1978608810 creator A5034031070 @default.
- W1978608810 creator A5048460698 @default.
- W1978608810 creator A5059068822 @default.
- W1978608810 creator A5091333725 @default.
- W1978608810 creator A5091695426 @default.
- W1978608810 date "2013-04-01" @default.
- W1978608810 modified "2023-10-18" @default.
- W1978608810 title "Phase 3 Randomized 3-Month Trial with an Ongoing 3-Month Safety Extension of Fixed-Combination Brinzolamide 1%/Brimonidine 0.2%" @default.
- W1978608810 cites W1963493193 @default.
- W1978608810 cites W1967560420 @default.
- W1978608810 cites W1973137327 @default.
- W1978608810 cites W2039015545 @default.
- W1978608810 cites W2067542801 @default.
- W1978608810 cites W2077659132 @default.
- W1978608810 cites W2082744863 @default.
- W1978608810 cites W2087041915 @default.
- W1978608810 cites W2108069709 @default.
- W1978608810 cites W2110897487 @default.
- W1978608810 cites W2140594570 @default.
- W1978608810 cites W2140758530 @default.
- W1978608810 cites W2147093603 @default.
- W1978608810 cites W2151027803 @default.
- W1978608810 cites W2162316179 @default.
- W1978608810 doi "https://doi.org/10.1089/jop.2012.0235" @default.
- W1978608810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3696917" @default.
- W1978608810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23425430" @default.
- W1978608810 hasPublicationYear "2013" @default.
- W1978608810 type Work @default.
- W1978608810 sameAs 1978608810 @default.
- W1978608810 citedByCount "37" @default.
- W1978608810 countsByYear W19786088102013 @default.
- W1978608810 countsByYear W19786088102014 @default.
- W1978608810 countsByYear W19786088102015 @default.
- W1978608810 countsByYear W19786088102016 @default.
- W1978608810 countsByYear W19786088102017 @default.
- W1978608810 countsByYear W19786088102018 @default.
- W1978608810 countsByYear W19786088102019 @default.
- W1978608810 countsByYear W19786088102020 @default.
- W1978608810 countsByYear W19786088102021 @default.
- W1978608810 countsByYear W19786088102022 @default.
- W1978608810 countsByYear W19786088102023 @default.
- W1978608810 crossrefType "journal-article" @default.
- W1978608810 hasAuthorship W1978608810A5034031070 @default.
- W1978608810 hasAuthorship W1978608810A5048460698 @default.
- W1978608810 hasAuthorship W1978608810A5059068822 @default.
- W1978608810 hasAuthorship W1978608810A5091333725 @default.
- W1978608810 hasAuthorship W1978608810A5091695426 @default.
- W1978608810 hasBestOaLocation W19786088102 @default.
- W1978608810 hasConcept C118487528 @default.
- W1978608810 hasConcept C126322002 @default.
- W1978608810 hasConcept C168563851 @default.
- W1978608810 hasConcept C203092338 @default.
- W1978608810 hasConcept C2776521421 @default.
- W1978608810 hasConcept C2778190193 @default.
- W1978608810 hasConcept C2778527774 @default.
- W1978608810 hasConcept C2781092963 @default.
- W1978608810 hasConcept C42219234 @default.
- W1978608810 hasConcept C71924100 @default.
- W1978608810 hasConceptScore W1978608810C118487528 @default.
- W1978608810 hasConceptScore W1978608810C126322002 @default.
- W1978608810 hasConceptScore W1978608810C168563851 @default.
- W1978608810 hasConceptScore W1978608810C203092338 @default.
- W1978608810 hasConceptScore W1978608810C2776521421 @default.
- W1978608810 hasConceptScore W1978608810C2778190193 @default.
- W1978608810 hasConceptScore W1978608810C2778527774 @default.
- W1978608810 hasConceptScore W1978608810C2781092963 @default.
- W1978608810 hasConceptScore W1978608810C42219234 @default.
- W1978608810 hasConceptScore W1978608810C71924100 @default.
- W1978608810 hasIssue "3" @default.
- W1978608810 hasLocation W19786088101 @default.
- W1978608810 hasLocation W19786088102 @default.
- W1978608810 hasLocation W19786088103 @default.
- W1978608810 hasLocation W19786088104 @default.
- W1978608810 hasOpenAccess W1978608810 @default.
- W1978608810 hasPrimaryLocation W19786088101 @default.
- W1978608810 hasRelatedWork W1945693830 @default.
- W1978608810 hasRelatedWork W1969739287 @default.
- W1978608810 hasRelatedWork W1975088893 @default.
- W1978608810 hasRelatedWork W2010738176 @default.
- W1978608810 hasRelatedWork W2020609742 @default.
- W1978608810 hasRelatedWork W2377183459 @default.
- W1978608810 hasRelatedWork W2416143983 @default.
- W1978608810 hasRelatedWork W2612340917 @default.
- W1978608810 hasRelatedWork W2970161030 @default.
- W1978608810 hasRelatedWork W4225277594 @default.
- W1978608810 hasVolume "29" @default.
- W1978608810 isParatext "false" @default.
- W1978608810 isRetracted "false" @default.
- W1978608810 magId "1978608810" @default.
- W1978608810 workType "article" @default.